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The management of snakebite injuries remains controversial and a 
source of endless fascination for surgeons. Treatment can seldom 
be based on the identity of the snake, as it is very unlikely that the 
offending reptile can be captured and accurately identified. For 
this reason, the current approach is a syndromic one, popularised 
by Blaylock[1] around the turn of the millennium and based on the 
clinical syndrome seen and the response to treatment. There are 
essentially three syndromes: painful progressive swelling (PPS), 
progressive weakness, and bleeding.[1] We have tended to follow this 
approach to the management of snakebite over the past 10 years 
at our institution in the western part of KwaZulu-Natal (KZN) 
Province, South Africa (SA). There is still an area of controversy 
surrounding the need for surgical intervention. Most patients will 
respond to non-operative care, but a subset will require surgery as 
part of their management.
The syndromic approach to management of snakebite recognises 
the fact that it is usually impossible to adequately identify the 
type of snake that has bitten the patient. The three recognisable 
clinical syndromes of PPS, progressive weakness and bleeding[1] 
correspond to the three venom types, namely cytotoxic, neurotoxic, 
and haemotoxic. If one of these syndromes has not manifested within 
1 hour of a snakebite, clinically significant envenomation is unlikely 
to have occurred.[2] According to Blaylock,[1] the therapeutic triad of 
elevation, intravenous fluids and analgesia is the mainstay of managing 
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Background. This audit of snakebites was undertaken to document our experience with snakebite in the western part of KwaZulu-Natal 
(KZN) Province, South Africa (SA).
Objective. To document our experience with snakebite in the western part of KZN, and to interrogate the data on patients who required 
some form of surgical intervention.
Methods. A retrospective study was undertaken at the Pietermaritzburg Metropolitan Trauma Service, Pietermaritzburg, SA. The Hybrid 
Electronic Medical Registry was reviewed for the 5-year period January 2012 - December 2016. All patients admitted to the service for 
management of snakebite were included.
Results. The offending snake is rarely identified, and the syndromic approach is now the mainstay of management. Most envenomations 
seen during the study period were cytotoxic, presenting with painful progressive swelling (PPS). We did not see any purely neurotoxic or 
haemotoxic envenomations. Antivenom is required for a subset of patients. The indications are essentially PPS that increases by >15 cm 
over an hour, PPS up to the elbow or knee after 4 hours, PPS of the whole limb after 8 hours, threatened airway, shortness of breath, 
associated clotting abnormalities and compartment syndrome. If no symptoms have manifested within 1 hour of a snakebite, clinically 
significant envenomation is unlikely to have occurred. Antivenom is associated with a high rate of anaphylaxis and should only be 
administered when absolutely indicated, preferably in a high-care setting under continuous monitoring. The need for surgery is less well 
defined. Urgent surgery is indicated for compartment syndrome of the limb, which is a potentially life- and limb-threatening condition. 
Its diagnosis is usually made clinically, but this is difficult in snakebites. Morbidity and cost increase dramatically once fasciotomy is 
required, as evidenced by much longer hospital stay. There is frequently a degree of cross-over between cytotoxicity and haemotoxicity 
in envenomations that require fasciotomy, which means that fasciotomy may result in catastrophic bleeding and should be preceded by 
the administration of antivenom, especially in patients with a low platelet count or a high international normalised ratio. Physiological 
and biochemical markers are unhelpful in assessing the need for fasciotomy. Objective methods include measurement of compartment 
pressures and ultrasound.
Conclusion. The syndromic management of snakebite is effective and safe. There is a high incidence of anaphylactic reactions to 
antivenom, and its administration must be closely supervised. In our area we overwhelmingly see cytotoxic snakebites with PPS. Surgery 
is often needed, and we need to refine our algorithms in terms of deciding on surgery.
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snakebites. Elevation is analgesic and diminishes venous swelling, and 
intravenous fluids replace the intravascular fluid that has extravasated 
into the tissues.[1] In addition to these basic supportive interventions, 
antivenom and surgery are two other interventions that need to be 
used selectively. Antivenom is needed for a subset of patients. In broad 
terms the indications include complications of PPS, rapid respiratory 
deterioration following neurotoxic envenomation, or uncontrolled 
bleeding.[1] Surgery is indicated mainly for compartment syndrome 
of the limbs, and debridement following tissue necrosis or secondary 
sepsis.[3]
Objective
This audit was undertaken to document our experience with 
snakebite in the western part of KZN, and to interrogate the data on 
patients who required some form of surgical intervention.
Methods
Clinical setting
This was a retrospective study undertaken at the Pietermaritzburg 
Metropolitan Trauma Service (PMTS) in Pietermaritzburg, the 
capital of KZN. The Hybrid Electronic Medical Registry (HEMR) was 
reviewed for the 5-year period January 2012 - December 2016. The 
PMTS provides definitive trauma care to the city of Pietermaritzburg. 
It is one of the largest academic trauma centres in KZN and also 
serves as the referral centre for 19 rural hospitals in the province, with 
a total catchment population of over three million.
The study
All patients admitted to our service for management of snakebite 
were included in this study. Basic demographic data, mechanism of 
injury and admission physiology were reviewed, as were all operative 
records. Details of the site of the snakebite, the type of syndrome, the 
clinical progression of the syndrome, the need for antivenom and 
need for operative management were recorded. The outcome of each 
operative intervention was documented. All in-hospital morbidities 
were reviewed.
The Zululand Scoring System (ZSS)
Wood et al.[4] have proposed a scoring system in snakebites to 
attempt to predict the likelihood of an active treatment intervention 
(ATI). ATI includes the administration of antivenom and any 
surgery (including debridements, amputations or fasciotomies). The 
scoring system allocates a point for each of age <14 years, admission 
>7 hours, white cell count >10 × 109/L, international normalised 
ratio (INR) >1.2, platelet count <92 × 109/L, and haemoglobin 
concentration <7.4 g/dL. Patients scoring ≥4 are predicted to require 
an ATI. We set out to use data from the HEMR to see whether the 
ZSS could be validated.
Ethics approval
Ethics approval for this study and for maintenance of the registry 
was obtained from the Biomedical Research Ethics Committee of the 
University of KwaZulu-Natal (ref. nos BE 207/09 and BCA 221/13).
Results
A total of 222 patients were admitted following a snakebite during 
the period under review. The male/female ratio was 1.36:1. The 
average age was 21.4 years. Just under half of the patients (47.8%) 
were <12 years of age, and just under a third (29.2%) were between 
12 and 35 years old. The snakebite was witnessed in 202 cases 
(91.0%), but the snake was positively identified in only 14 cases 
(6.3%). The sites of the bites are listed in Table 1. A tourniquet was 
applied in 8 cases (3.6%). These were applied at the base hospital. 
The bites were venomous in 200 cases (90.1%) and either non-
venomous or a ‘dry bite’ in the remainder. In 99.1% of cases there 
was a single bite. Of the bites that were venomous, 187 (93.5%) 
were cytotoxic and 13 (6.5%) were cytotoxic and haemotoxic. 
There were no pure haemotoxic or neurotoxic bites. Eighteen 
patients (8.1%) required intensive care unit (ICU) or high-care 
admission. In 8 cases (44.4%) this was because of complications of 
the envenomation, and in 10 cases (55.6%) because of anaphylaxis 
from antivenom administration.
Antivenom
Antivenom was required in 28 patients (12.6%). Compared with 
older patients, more patients aged <20 years received antivenom 
(58.6%). The rate of anaphylaxis was 42.9%. Children (<12 years) 
were most likely to develop anaphylaxis (58.3%). We did not have 
any mortality as a result of anaphylaxis, although 13 patients (46.4%) 
who received antivenom required ICU or high-care admission. 
Four of these patients required ventilation, 1 as a result of airway 
compromise after cytotoxic envenomation, and 3 as a consequence 
of anaphylaxis. Twelve patients (42.9%) who received antivenom 
required fasciotomy. The average length of stay for a patient who 
received antivenom was 7.5 days, compared with 2.8 days for those 
who had simple management.
Surgery
An operation was required in 33 patients (14.9%). Fasciotomy was 
performed in 14 patients (6.3%). The male/female ratio of patients 
who required fasciotomy was 1.56:1. A large proportion of patients 
requiring fasciotomy (50.0%) were between the ages of 13 and 35 
years. Fasciotomies were performed equally on the upper and lower 
limbs, and equally on patients over and under 20 years of age. A 
total of 6 patients (42.9%) who underwent fasciotomy required high-
care or ICU admission postoperatively. Over two-thirds (78.6%) 
of patients who required fasciotomy needed follow-up surgery for 
debridement, grafting or closure. The remainder healed by secondary 
intention, were grafted at base or were lost to follow-up. The average 
length of hospital stay for patients who received fasciotomy was 13.1 
days. This is 10 days longer than the average hospital stay for patients 
with snakebite who received simple management. Other types of 
surgery included 16 debridements (7.2%), 12 split-skin grafts (5.4%), 
and 3 incision and drainages (1.4%). One amputation and one tendon 
repair were required.
Complications
The following complications were recorded: compartment syndrome 
5.9%, acute kidney injury 2.7% and respiratory distress 2.3%. One 
patient had iatrogenic tendon injury during fasciotomy.
Table 1. Sites of the snakebites
Area bitten Patients, %
Toes 4.1
Foot 47.8
Leg 19.4
Thigh 1.4
Fingers 3.6
Hand 13.5
Forearm 5.4
Upper arm 1.4
Head and neck 2.3
Trunk 1.4
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The Zululand Scoring System
A total of 44 of our patients required an ATI. Of these, 15 had scores 
of ≥4 points according to Wood et al.’s[4] ZSS (therefore predicting 
the need for ATI), which gives a positive predictive value of only 
34.1%. Of the remaining patients (who did not require an ATI), 78 
had sufficient data for a score to be calculated and of these 17 scored 
≥4 points, providing a negative predictive value of 78.2%.
Discussion
The management of snakebite depends on the type of envenomation. 
However, the snake is very seldom identified and clinicians have 
to manage the bite according to a syndromic approach popularised 
by Blaylock from Eshowe Hospital in KZN. The most common 
syndrome has been reported as PPS from cytotoxic venom, most 
usually due to a bite from a puff adder, rinkhals or Mozambique 
spitting cobra,[1,5] which is very much in keeping with our findings. 
We did not manage any purely neurotoxic or haemotoxic bites. This 
contrasts with reports from our sister institution in Zululand,[5] 
reflecting the fact that the distribution of the two most notorious 
neurotoxic snakes, the black and green mambas, is largely in the 
coastal regions of KZN. The incidence of black mamba bites may in 
fact be under-reported, as these cases may not reach hospital. The 
surgical burden in Zululand is lower than in Pietermaritzburg.[5] 
Purely haemotoxic bites are rare because of the timid nature of the 
two haemotoxic snakes, the boomslang and vine snake (twig snake). 
The variation of the distribution of poisonous snakes in KZN is 
shown in Tables 2 and 3.
Antivenom is needed for a subset of patients. There are two major 
types of antivenom available, namely polyvalent and monovalent, 
produced by South African Vaccine Producers (SAVP). Polyvalent 
antivenom is available as an emergency stock item in most hospitals. 
A list of snakes that polyvalent antivenom is effective against 
is provided in Table 4. Monovalent antivenom is specific to the 
boomslang and must be ordered specifically from SAVP. A list of links 
and contact details is provided in Table 5. According to Blaylock,[1] the 
indications for antivenom in patients with PPS, our most commonly 
encountered scenario, include PPS that increases by >15 cm over 
an hour, PPS up to the elbow or knee 4 hours after envenomation, 
PPS of the whole limb after 8 hours, threatened airway, shortness 
of breath, associated clotting abnormalities and compartment 
syndrome. The indications for antivenom administration are listed 
in Table 6. The administration of antivenom is associated with a 
high rate of anaphylaxis.[5] Our rate of anaphylaxis was 42.9%, which 
is very much in keeping with reports by other local authors such as 
Wood et al.,[5] who had a rate of anaphylaxis of 23% (up to 43% in the 
10 - 20-year age group). Antivenom must be administered in a high-
care setting under continuous monitoring. We follow Wood et al.’s[5] 
recommendation to administer a dose of intramuscular adrenaline 
prior to antivenom administration. Although we had no deaths 
associated with anaphylaxis, just under half of the patients (46.4%) 
who received antivenom required ICU or high-care admission. More 
patients aged <20 years than older patients received antivenom. 
This is in keeping with Wood et al.’s[5] findings. These authors 
felt that the smaller size of the child in conjunction with equal 
envenomation from a bite meant that children were more likely to 
require antivenom than adults.[5] Children (<12 years) were more 
likely to develop anaphylaxis (58.3%), which is also in keeping with 
Wood et al.’s[5] findings. The protocol for antivenom administration 
is set out in Table 7.
The need for surgery is less well defined. Urgent surgery is 
required to manage a compartment syndrome of the limb, which 
is a potentially life- and limb-threatening condition traditionally 
diagnosed clinically by a tense and swollen limb with decreased 
perfusion.[3] This diagnosis is difficult, as a snake envenomation often 
mimics a compartment syndrome.[3] This is because the majority 
of cases are exquisitely tender and have ‘pain on passive stretch’ 
despite the absence of a true compartment syndrome. More reliable 
signs are a tense compartment with distal loss of sensation. Loss of 
distal pulse is a late sign. The situation in snakebite is complicated 
by the fact that the swelling may be confined to the subcutaneous 
fat and skin, not truly reflecting a compartment syndrome of the 
deep compartments.[6] Morbidity and cost increase dramatically once 
Table 2. Poisonous snakes most commonly found in Zululand
Puff adder (Bitis arietans)
Night adder (Causinae rhombeatus)
Gaboon viper (Bitis gabonica)
Mozambique spitting cobra (Naja mossambica)
Rinkhals (Hemachatus haemachatus)
Zebra, western barred, or black spitting cobra (Naja nigricincta)
Forest or white-lipped cobra (Naja melanoleuca)
Snouted or banded Egyptian cobra (Naja annulifera)
Black mamba (Dendroaspis polylepis)
Green mamba (Dendroaspis angusticeps)
Vine or twig snake (Thelotornis species)
Boomslang (Dispholidus typus)
Table 3. Poisonous snakes most commonly found in the 
Pietermaritzburg area
Night adder (Causinae rhombeatus)
Puff adder (Bitis arietans)
Rinkhals (Hemachatus haemachatus)
Black mamba (Dendroaspis polylepis)*
Boomslang (Dispholidus typus)
*Less common than in the Zululand area.
Table 4. Envenomations for which polyvalent antivenom is 
effective
Puff adder (Bitis arietans)
Gaboon adder (Bitis gabonica)
Rinkhals (Haemachatus haemachatus)
Green mamba (Dendroaspis angusticeps)
Black mamba (Dendroaspis polylepsis)
Jameson’s mamba (Dendroaspis jamesoni)
Cape cobra (Naja nivea)
Forest cobra (Naja melanoleuca)
Snouted (Egyptian) cobra (Naja annulifera)
Mozambique spitting cobra (Naja mossambica)
Table 5. South African Vaccine Producers contact details
Business hours 011 386 6063/2
After-hours emergency 011 386 6000
Fax 011 386 6016
E-mail megans@savp.co.za
cillaf@savp.co.za
Physical address SAVP, Modderfontein Road, 
Sandringham, Johannesburg, 
South Africa
Postal address PO Box 28999, Sandringham, 
Johannesburg, 2131
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fasciotomy is required, as evidenced by the much longer hospital 
stay. This highlights the importance of not performing fasciotomies 
unnecessarily. While our fasciotomy rate may be appropriate for a 
referral hospital, it must be kept in mind that some fasciotomies 
may have been performed unnecessarily and that clinical assessment 
alone, considering all its limitations in snakebites, may not be 
sufficient in deciding on the need for fasciotomy. Physiological 
and biochemical markers are unhelpful in assessing the need for 
fasciotomy. Objective methods include measuring of compartment 
pressures and ultrasound.[6] Measuring of compartment pressures 
is a painful, invasive and cumbersome technique. Wood et al.[4] 
have advocated the use of ultrasound as a painless and non-invasive 
technique of diagnosing compartment syndrome in snakebites. 
In Wood et al.’s[6] study of ultrasound findings in 42 patients with 
cytotoxic snakebites, it was found that swelling was most commonly 
confined to the subcutaneous tissues, with the muscle compartment 
seldom affected. When intramuscular swelling is demonstrated, 
the diagnosis of compartment syndrome should be considered.[6] 
Ultrasound may therefore provide the answer.
There is frequently a degree of cross-over between cytotoxicity 
and haemotoxicity in cytotoxic envenomations. This means that 
fasciotomy may result in catastrophic bleeding and should be 
preceded by the administration of antivenom, especially in patients 
with a low platelet count or a high INR.[3] Deranged clotting profiles 
or low platelets will be resistant to correction until antivenom 
has been given. Our institution follows a protocol of antivenom 
administration prior to fasciotomy to reduce intraoperative 
bleeding. Only patients who underwent fasciotomy did not receive 
antivenom, and these were delayed presentations (>48 hours after 
envenomation).
Conclusion
The syndromic management of snakebite is effective and safe. 
There is a high incidence of anaphylactic reactions to antivenom, 
and its administration must be closely supervised. In our area we 
overwhelmingly see cytotoxic snakebites with PPS. Surgery is often 
needed, and we need to refine our algorithms in terms of deciding 
on surgery.
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Table 7. Protocol for antivenom administration[5]
Discuss with emergency medicine or surgery consultant prior to administration
Doctor with airway skills and appropriate drugs and equipment for urgent intubation and ventilation on standby
Facemask oxygen and two large-bore intravenous lines
Continuous pulse, blood pressure, and oxygen saturation monitoring
Resuscitation trolley and defibrillator on standby
Intramuscular or subcutaneous adrenaline 0.3 - 0.5 mg (0.01 mg/kg in children) prior to antivenom administration (hydrocortisone  
and promethazine are no longer given routinely)
Polyvalent antivenom 80 mL over 15 minutes (a repeat dose may be given if symptoms continue to progress in 1 - 2 hours)
Table 6. Indications for antivenom administration[1]
Cytotoxic (PPS) Neurotoxic (progressive weakness) Haemotoxic (bleeding)
Swelling extending at 15 cm or more for 1 hour
Swelling to the elbow or knee by 3 - 4 hours
Swelling of a whole limb within 8 hours
Swelling threatening the airway
Associated unexplained shortness of breath
Associated abnormality of blood clotting (or 
prior to fasciotomy)
Compartment syndrome or compressed major 
blood vessel
Pins and needles, profuse sweating, and 
excessive salivation (or metallic taste) after 
mamba envenomation
Shortness of breath due to weakness in the 
absence of PPS
Inability to swallow saliva
Generalised weakness in the presence of PPS or 
generalised muscle pain
Fang punctures do not stop bleeding and/
or severe headaches, dizziness, fainting or 
convulsions
Active systemic bleeding (not bruising of 
the bitten limb alone)
Non-clotting blood after 20 minutes in an 
undisturbed, new, dry, clean test tube. Use 
blood from a healthy person as a control
Significant laboratory evidence of a blood 
clotting abnormality
PPS = painful progressive swelling.
